한글목차

세계 폐쇄형 수술 후 배액(Closed Type Postoperative Drainage) 시장을 조사했으며, 시장 정의와 개요, 시장 성장에 영향을 미치는 요인과 시장 기회 분석, 상환 환경, 시장 규모 추이 및 예측, 각종 부문별/지역별 분석, 경쟁 환경, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 주요 요약

제2장 시장 개요

제3장 조사 방법

제4장 시장 역학

• 개요
• 성장 촉진요인
• 성장 억제요인
• 기회

제5장 시장 요인 분석

• 밸류체인 분석
• Porter's Five Forces 모델
• COVID-19가 세계의 폐쇄형 수술 후 배액 시장에 미치는 영향
• 상환 시나리오

제6장 세계의 폐쇄형 수술 후 배액 시장 : 제품별

• 개요
• 폐쇄형 수술후 배액 시스템
• 부속품

제7장 세계의 폐쇄형 수술 후 배액 시장 : 유형별

• 개요
• 액티브 배액
• 패시브 배액

제8장 세계의 폐쇄형 수술 후 배액 시장 : 연령층별

• 개요
• 성인
• 소아

제9장 세계의 폐쇄형 수술 후 배액 시장 : 용도별

• 개요
• 일반 외과
• 정형외과
• 심장 및 흉부외과
• 산과 및 부인과 외과
• 기타

제10장 세계의 폐쇄형 수술 후 배액 시장 : 최종사용자별

• 개요
• 병원 및 진료소
• 외래수술센터(ASC)
• 기타

제11장 세계의 폐쇄형 수술 후 배액 시장 : 지역별

• 개요
• 북미
• 유럽
• 아시아태평양
• 기타 지역

제12장 경쟁 구도

• 개요
• 경쟁 벤치마킹
• 주요 성장 전략
• 개발 건수 기준 주요 기업
• 재무 매트릭스

제13장 기업 개요

• CARDINAL HEALTH
• ZIMMER BIOMET
• AXIOM MEDICAL, INC
• ANGIPLAST PVT. LTD
• POLYMEDICURE
• BECTON, DICKINSON AND COMPANY
• B. BRAUN SE
• STAYGUARD
• MEDLINE INDUSTRIES, INC
• VARIVAC INTERNATIONAL MEDICAL RESEARCH PTY LTD

제14장 부록

영문목차

Cardinal Health (US), Zimmer Biomet (US), Axiom Medical, Inc. (US), Angiplast Pvt. Ltd. (India), Polymedicure (India), Becton, Dickinson, and Company (US), Braun SE (Germany), StayGuard (US), Medline Industries, Inc. (US), and VariVac International Medical Research Pty Ltd. (Australia), Ingelheim (Ingelheim am Rhein, Germany), Vetoquinol (Lure, France), Ceva Animal Health, LLC (Libourne, France), Chanelle Pharma (Galway, Ireland), Elanco (Indiana, US), SOMAVAC Medical Solutions, Inc. (US).

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

• 1.1 OVERVIEW

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE
• 2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

• 3.1 DATA MINING
• 3.2 SECONDARY RESEARCH
• 3.3 PRIMARY RESEARCH
• 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
• 3.5 FORECASTING TECHNIQUES
• 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
  • 3.6.1 BOTTOM-UP APPROACH
  • 3.6.2 TOP-DOWN APPROACH
• 3.7 DATA TRIANGULATION
• 3.8 VALIDATION

4 MARKET DYNAMICS

• 4.1 OVERVIEW
• 4.2 DRIVERS
  • 4.2.1 INCREASING INCIDENCE OF CHRONIC WOUNDS AND SURGICAL SITE INFECTIONS
  • 4.2.2 RISING PREVALENCE OF CHRONIC DISEASES
  • 4.2.3 RISING AWARENESS ABOUT THE BENEFITS OF CLOSED SURGICAL WOUND DRAINAGE AND TECHNOLOGICAL ADVANCEMENTS
• 4.3 RESTRAINTS
  • 4.3.1 INCREASING CONCERNS OVER SIDE EFFECTS
  • 4.3.2 RISE IN THE NUMBER OF MINIMALLY INVASIVE SURGERIES
• 4.4 OPPORTUNITIES
  • 4.4.1 GROWING AGING POPULATION

5 MARKET FACTOR ANALYSIS

• 5.1 VALUE CHAIN ANALYSIS
  • 5.1.1 R&D & DESIGNING
  • 5.1.2 MANUFACTURING
  • 5.1.3 DISTRIBUTION & SALES
  • 5.1.4 POST-SALES MONITORING
• 5.2 PORTER'S FIVE FORCES MODEL
  • 5.2.1 THREAT OF NEW ENTRANTS
  • 5.2.2 BARGAINING POWER OF SUPPLIERS
  • 5.2.3 THREAT OF SUBSTITUTES
  • 5.2.4 BARGAINING POWER OF BUYERS
  • 5.2.5 INTENSITY OF RIVALRY
• 5.3 IMPACT OF COVID-19 ON THE GLOBAL CLOSED SURGICAL WOUND DRAINAGE MARKET
  • 5.3.1 IMPACT ON MARKET GROWTH
  • 5.3.2 DEMAND SUPPLY ANALYSIS
  • 5.3.3 IMPACT ON KEY PLAYERS
• 5.4 REIMBURSEMENT SCENARIO FOR CLOSED SURGICAL WOUND DRAINAGE
  • 5.4.1 REIMBURSEMENT SCENARIO BY COUNTRY

6 GLOBAL CLOSED SURGICAL WOUND DRAINAGE MARKET, BY PRODUCT

• 6.1 OVERVIEW
• 6.2 CLOSED SURGICAL DRAINAGE SYSTEMS
• 6.3 ACCESSORIES

7 GLOBAL CLOSED SURGICAL WOUND DRAINAGE MARKET, BY TYPE

• 7.1 OVERVIEW
• 7.2 ACTIVE DRAINS
• 7.3 PASSIVE DRAINS

8 GLOBAL CLOSED SURGICAL WOUND DRAINAGE MARKET, BY AGE GROUP

• 8.1 OVERVIEW
• 8.2 ADULT
• 8.3 PAEDIATRIC

9 GLOBAL CLOSED SURGICAL WOUND DRAINAGE MARKET, BY APPLICATION

• 9.1 OVERVIEW
• 9.2 GENERAL SURGERY
• 9.3 ORTHOPEDICS SURGERY
• 9.4 CARDIAC & THORACIC SURGERY
• 9.5 OBSTETRIC/GYNECOLOGICAL SURGERY
• 9.6 OTHERS

10 GLOBAL CLOSED SURGICAL WOUND DRAINAGE MARKET, BY END USER

• 10.1 OVERVIEW
• 10.2 HOSPITALS & CLINICS
• 10.3 AMBULATORY SURGICAL CENTERS
• 10.4 OTHERS

11 GLOBAL CLOSED SURGICAL WOUND DRAINAGE MARKET, BY REGION

• 11.1 OVERVIEW
• 11.2 NORTH AMERICA
  • 11.2.1 US
  • 11.2.2 CANADA
• 11.3 EUROPE
  • 11.3.1 GERMANY
  • 11.3.2 FRANCE
  • 11.3.3 UK
  • 11.3.4 ITALY
  • 11.3.5 SPAIN
  • 11.3.6 REST OF EUROPE
• 11.4 ASIA-PACIFIC
  • 11.4.1 CHINA
  • 11.4.2 INDIA
  • 11.4.3 JAPAN
  • 11.4.4 SOUTH KOREA
  • 11.4.5 AUSTRALIA
  • 11.4.6 REST OF ASIA-PACIFIC
• 11.5 REST OF THE WORLD
  • 11.5.1 AFRICA
  • 11.5.2 LATIN AMERICA
  • 11.5.3 MIDDLE EAST

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 COMPETITIVE BENCHMARKING
• 12.3 MAJOR GROWTH STRATEGY IN THE GLOBAL CLOSED SURGICAL WOUND DRAINAGE MARKET
• 12.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL CLOSED SURGICAL WOUND DRAINAGE MARKET
• 12.5 FINANCIAL MATRIX
  • 12.5.1 SALES (USD MILLION), 2022
  • 12.5.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2022

13 COMPANY PROFILES

• 13.1 CARDINAL HEALTH
  • 13.1.1 COMPANY OVERVIEW
  • 13.1.2 FINANCIAL OVERVIEW
  • 13.1.3 PRODUCTS OFFERED
  • 13.1.4 KEY DEVELOPMENTS
  • 13.1.5 SWOT ANALYSIS
  • 13.1.6 KEY STRATEGIES
• 13.2 ZIMMER BIOMET
  • 13.2.1 COMPANY OVERVIEW
  • 13.2.2 FINANCIAL OVERVIEW
  • 13.2.3 PRODUCTS OFFERED
  • 13.2.4 KEY DEVELOPMENTS
  • 13.2.5 SWOT ANALYSIS
  • 13.2.6 KEY STRATEGIES
• 13.3 AXIOM MEDICAL, INC
  • 13.3.1 COMPANY OVERVIEWS
  • 13.3.2 FINANCIAL OVERVIEW
  • 13.3.3 PRODUCTS OFFERED
  • 13.3.4 KEY DEVELOPMENTS
  • 13.3.5 KEY STRATEGIES
• 13.4 ANGIPLAST PVT. LTD
  • 13.4.1 COMPANY OVERVIEW
  • 13.4.2 FINANCIAL OVERVIEW
  • 13.4.3 PRODUCTS OFFERED
  • 13.4.4 KEY DEVELOPMENTS
  • 13.4.5 KEY STRATEGIES
• 13.5 POLYMEDICURE
  • 13.5.1 COMPANY OVERVIEW
  • 13.5.2 FINANCIAL OVERVIEW
  • 13.5.3 PRODUCTS OFFERED
  • 13.5.4 KEY DEVELOPMENTS
  • 13.5.5 KEY STRATEGIES
• 13.6 BECTON, DICKINSON AND COMPANY
  • 13.6.1 COMPANY OVERVIEW
  • 13.6.2 FINANCIAL OVERVIEW
  • 13.6.3 PRODUCTS OFFERED
  • 13.6.4 KEY DEVELOPMENTS
  • 13.6.5 SWOT ANALYSIS
  • 13.6.6 KEY STRATEGIES
• 13.7 B. BRAUN SE
  • 13.7.1 COMPANY OVERVIEW
  • 13.7.2 FINANCIAL OVERVIEW
  • 13.7.3 PRODUCTS OFFERED
  • 13.7.4 KEY DEVELOPMENTS
  • 13.7.5 SWOT ANALYSIS
  • 13.7.6 KEY STRATEGIES
• 13.8 STAYGUARD
  • 13.8.1 COMPANY OVERVIEW
  • 13.8.2 PRODUCTS OFFERED
  • 13.8.3 KEY DEVELOPMENTS
  • 13.8.4 KEY STRATEGIES
• 13.9 MEDLINE INDUSTRIES, INC
  • 13.9.1 COMPANY OVERVIEW
  • 13.9.2 FINANCIAL OVERVIEW
  • 13.9.3 PRODUCTS OFFERED
  • 13.9.4 KEY DEVELOPMENTS
  • 13.9.5 SWOT ANALYSIS
  • 13.9.6 KEY STRATEGIES
• 13.10 VARIVAC INTERNATIONAL MEDICAL RESEARCH PTY LTD
  • 13.10.1 COMPANY OVERVIEW
  • 13.10.2 FINANCIAL OVERVIEW
  • 13.10.3 PRODUCTS OFFERED
  • 13.10.4 KEY DEVELOPMENTS
  • 13.10.5 KEY STRATEGIES

14 APPENDIX

• 14.1 REFERENCES
• 14.2 RELATED REPORTS